BRITISH JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2024-10-31 暗影的太阳来自湖南省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：食管;手术;新辅助
经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。
也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2021-06-10 godweiZ

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：食管癌
经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。

268 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2024-05-10 ms3000000760145879 来自上海

Under consideration 25天了救命这合理吗？？？

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2024-07-30 ms3000000242801209 来自河南省

这本期刊为什么被北方某医院给预警了？

87 0

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2023-09-18 nenee 来自湖北省

偏重的研究方向：乳腺癌;肿瘤
经验分享：请问under consideration 两周了是怎么回事呢

175 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2022-06-23 ms3000000859573514

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤治疗
经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火

199 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2020-01-08 18900911270haoliangdut

请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表:
有救

138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救

317 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2023-08-27 docL 来自上海

偏重的研究方向：分子标记物
经验分享：100天了，还没找到审稿人

185 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2022-09-12 Glori

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久

212 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2234409, encodeId=61cb2234409b3, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：食管;手术;新辅助 经验分享：投了一个月，连编辑都没有分配，直接拒了，两周的时候催过一次也没什么效果，大家急的话慎投吧。 也不要相信**公众号说中稿率高，这杂志近几年影响因子上去了又跌下来了，估计现在卡得严。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05a25572181, createdName=暗影的太阳, createdTime=Thu Oct 31 20:34:44 CST 2024, time=2024-10-31, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203912, encodeId=3518220391273, content=Under consideration 25天了救命这合理吗？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca575379633, createdName=ms3000000760145879, createdTime=Fri May 10 15:28:31 CST 2024, time=2024-05-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2217646, encodeId=085b221e646fc, content=这本期刊为什么被北方某医院给预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ed58151085, createdName=ms3000000242801209, createdTime=Tue Jul 30 19:33:11 CST 2024, time=2024-07-30, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海)]

2023-02-16 ms1000001023607781 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤样本测序数据分析
经验分享：Stage Start Date
Decision made 7th Jan 23
Under review 12th Sep 22
Under consideration 30th Aug 22
Author Approved Converted Files 30th Aug 22
Under submission 29th Aug 22
审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！

153 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务